MetLifeMET -3.90%76 EBITDA Margin % is 9.52% as of Mar. 2026, which is 15% below its 10-year median of 11.17. GuruFocus rates MET with a GF Score™ of 76/100 and a GF Value™ of $89.60 (Fairly Valued). The stock has 8 warning signs investors should review. Among 371 Insurance companies, MetLife ranks worse than 77.36% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. MetLife's EBITDA for the
three
months ended in Mar. 2026 was $1,772 Mil. MetLife's Revenue for the
three
months ended in Mar. 2026 was $18,616 Mil. Therefore, MetLife's EBITDA margin for the quarter that ended in Mar. 2026 was 9.52%.
MetLife (NYSE:MET) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
MetLife EBITDA Margin % Related Terms
MetLife EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for MetLife's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Insurance - Life subindustry, MetLife's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MetLife EBITDA Margin % vs Insurance Industry
For the Insurance industry and Financial Services sector, MetLife's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where MetLife's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MetLife (MET) has a EBITDA Margin % of 9.52% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on MetLife and its competitors. This is 15% below median its historical median of 11.17. Over the past decade, MetLife's EBITDA Margin % has ranged from 5.78 to 15.99. According to the industry distribution chart, MetLife ranks #287 out of 371 companies in the Insurance industry, placing it in the top 77.4%.
Is MetLife's EBITDA Margin % too high?
MetLife's current EBITDA Margin % of 9.52% is 15% below median its 10-year median of 11.17. Over the past 10 years, this metric has ranged from a low of 5.78 to a high of 15.99. The Insurance industry median EBITDA Margin % is 14.91. MetLife's value of 9.52% is 36.2% below this industry median. Based on the distribution chart, MetLife ranks #287 out of 371 companies in the Insurance industry, which is in the bottom quartile relative to peers. Overall, MetLife has a GF Score™ of 76/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does MetLife's EBITDA Margin % compare to AFL and PRU?
According to the Insurance industry distribution chart, MetLife ranks #287 out of 371 companies for EBITDA Margin %. This places MetLife in the lower half of its industry. The industry median EBITDA Margin % is 14.91. MetLife's value of 9.52% is 36.2% below this benchmark. Historically, MetLife's own EBITDA Margin % has ranged from 5.78 to 15.99 over the past decade. While the company's 10-year median is 11.17 vs. the industry median of 14.91, MetLife has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for an Insurance company?
The median EBITDA Margin % among Insurance companies is 14.91, based on 371 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MetLife's current EBITDA Margin % of 9.52% is 36.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on MetLife and its competitors. For the Insurance industry, the median EBITDA Margin % is 14.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MetLife's current EBITDA Margin % is 9.52%, which is 15% below median its own 10-year median of 11.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MetLife stock overvalued right now?
Based on GuruFocus' analysis, MetLife (MET) is currently considered Fairly Valued. The stock's GF Value™ is $89.60, compared to a current price of $84.60 — trading 5.6% below its estimated fair value. The current EBITDA Margin % is 9.52%, which is 15% below median its 10-year median of 11.17 and 36.2% below the Insurance industry median of 14.91. MetLife's overall GF Score™ is 76/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For MetLife (MET), the current EBITDA Margin % is 9.52% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MetLife (MET) Overvalued in 2026?
Based on GuruFocus' analysis, MetLife stock appears to be undervalued.
The current stock price of $84.60 is trading 5.6% below its estimated GF Value™ of $89.60.
GuruFocus considers MetLife to be Fairly Valued.
Key valuation signals for MET:
EBITDA Margin %: 9.52% (15% below median its 10-year median of 11.17)
GF Value™: $89.60 vs. price of $84.60 (5.6% below fair value)
Industry Position: 36.2% below the Insurance median (#287 of 371)
No single metric tells the full story. See the MET stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MetLife is one of the largest life insurers in the US by assets and provides a variety of life insurance and annuity products. It is organized into six segments: Group Benefits, Retirement and Income Solutions, Asia, Latin America, Europe/Middle East/Africa (EMEA), and MetLife Holdings (products in run-off). Group Benefits and RIS are US-based, contributing to around 48% of the firm's 2024 adjusted earnings. The Asia segment contributes around 25% of earnings, mainly tied to Japan. The company also holds leading market positions in Mexico and Chile, with the Latin America segment contributing around 13% of 2024 earnings. The EMEA and MetLife Holdings segments contributed around 4% and 10% of 2024 earnings, respectively.
76GF Score
Get the complete analysis for MET
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MET has been successfully added to your 
